Cargando…
Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives
SIMPLE SUMMARY: The estimated survival time for glioblastoma patients is extremely low; only about 5% of patients survive five years post diagnosis. The standard of care for glioblastoma patients involves surgery, radiation therapy, and chemotherapy with temozolomide. However, due to the extremely i...
Autores principales: | Seker-Polat, Fidan, Pinarbasi Degirmenci, Nareg, Solaroglu, Ihsan, Bagci-Onder, Tugba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773542/ https://www.ncbi.nlm.nih.gov/pubmed/35053605 http://dx.doi.org/10.3390/cancers14020443 |
Ejemplares similares
-
Chronically Radiation-Exposed Survivor Glioblastoma Cells Display Poor Response to Chk1 Inhibition under Hypoxia
por: Pinarbasi-Degirmenci, Nareg, et al.
Publicado: (2022) -
Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma
por: Senbabaoglu, Filiz, et al.
Publicado: (2020) -
DDRE-03. IDH1-MUTANT GBM CELLS ARE HIGHLY SENSITIVE TO COMBINATION OF KDM6A/B AND HDAC INHIBITORS
por: Kayabölen, Alişan, et al.
Publicado: (2021) -
Protein Scaffold‐Based Multimerization of Soluble ACE2 Efficiently Blocks SARS‐CoV‐2 Infection In Vitro and In Vivo
por: Kayabolen, Alisan, et al.
Publicado: (2022) -
The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme
por: Kaya-Aksoy, Ezgi, et al.
Publicado: (2019)